CLINICAL_TRIALS
trial_result
· 2011-10-05
Clinical Trial Update: Provision of Antioxidant Therapy in Hemodialysis (PATH) Study [Phase 2]
Summary
Phase 2 PATH trial assessed antioxidant therapy in end-stage renal disease patients undergoing hemodialysis; results were posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Vanderbilt University | Conditions: End-stage Renal Disease | Phase 2 | Status: COMPLETED | Results posted: 2011-10-05